A living evidence approach treats evidence as shared infrastructure rather than as a series of isolated projects.

Key highlights from the Type C FDA meeting include: FDA confirms the approach that the proposed primary endpoint of the ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a highly prevalent chronic liver condition globally, with its management spanning ...

The day when quantum computers will be able to break conventional encryption is rapidly approaching, but not all companies are prepared to implement post-quantum cryptography.

The D Bank of Wales has led a £1 million Series A equity investment round, with a £700,000 equity investment in Academii, the ...

Study of 100+ energy OT sites reveals unpatched devices, flat networks, and hidden assets, with critical issues detected within minutes.

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

Modern ransomware has shifted from encryption to psychological extortion that exploits fear, liability, and exposure. Flare ...

The Survey situates India's recent performance within a global environment characterised by persistent geopolitical ...

The Global BYOD Enterprise Mobility Market Size projected to grow at a CAGR of 15.99% from 2026 to 2032, according to a new ...

Investing.com -- OKYO Pharma Limited (NASDAQ:OKYO) stock climbed 4.7% Wednesday after the company announced successful discussions with the FDA regarding its Phase 2b/3 clinical trial design for ...

Avobis Bio LLC, a clinical stage company developing implantable cell therapies, announced that expanded primary analysis ...